Original Article

You have full text access to this OnlineOpen article

Association of marijuana use and the incidence of testicular germ cell tumors

  1. Janet R. Daling PhD1,2,†,*,
  2. David R. Doody MS1,
  3. Xiaofei Sun BS3,
  4. Britton L. Trabert MS, MSPH1,2,
  5. Noel S. Weiss MD, DrPH1,2,
  6. Chu Chen PhD1,2,
  7. Mary L. Biggs PhD1,4,
  8. Jacqueline R. Starr PhD1,2,5,
  9. Sudhansu K. Dey PhD6,
  10. Stephen M. Schwartz PhD1,2

Article first published online: 9 FEB 2009

DOI: 10.1002/cncr.24159

Issue

Cancer

Cancer

Volume 115, Issue 6, pages 1215–1223, 15 March 2009

Additional Information

How to Cite

Daling, J. R., Doody, D. R., Sun, X., Trabert, B. L., Weiss, N. S., Chen, C., Biggs, M. L., Starr, J. R., Dey, S. K. and Schwartz, S. M. (2009), Association of marijuana use and the incidence of testicular germ cell tumors. Cancer, 115: 1215–1223. doi: 10.1002/cncr.24159

Author Information

  1. 1

    Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington

  2. 2

    Department of Epidemiology, School of Public Health and Community Medicine, University of Washington, Seattle, Washington

  3. 3

    Department of Pediatrics, Vanderbilt University Medical Center, Nashville, Tennessee

  4. 4

    Department of Biostatistics, School of Public Health and Community Medicine, University of Washington, Seattle, Washington

  5. 5

    Department of Pediatrics, School of Medicine, University of Washington, Seattle, Washington

  6. 6

    Cincinnati Children's Research Foundation, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio

  1. †

    Fax: (206) 667-5948

*Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, PO Box 19024, Seattle, WA 98109

Publication History

  1. Issue published online: 3 MAR 2009
  2. Article first published online: 9 FEB 2009
  3. Manuscript Accepted: 3 OCT 2008
  4. Manuscript Revised: 29 SEP 2008
  5. Manuscript Received: 4 AUG 2008

Funded by

  • National Institutes of Health. Grant Numbers: R01CA085914, NO1-PC-35142
  • Fred Hutchinson Cancer Research Center
  • National Institute on Drug Abuse. Grant Number: R37DA06668

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (133K)

References

  • 1
    Reis LAG, Melbert D, Krapcho M, et al. SEER Cancer Statistics Review, 1975-2004 (based on the November 2006 submission; posted to the SEER website in 2007). Bethesda, Md: National Cancer Institute; 2007. Available at: http://seer.cancer.gov/csr/1975_2004/. Accessed February 4, 2008.
  • 2
    McGlynn KA, Devesa SS, Sigurdson AJ, Brown LM, Tsao L, Tarone RE. Trends in the incidence of testicular germ cell tumors in the United States. Cancer. 2003; 97: 63-70.
    Direct Link:
  • 3
    Verhoeven R, Houterman S, Kiemeney B, Koldewijn E, Coebergh JW. Testicular cancer: marked birth cohort effects on incidence and a decline in mortality in southern Netherlands since 1970. Int J Cancer. 2008; 122: 639-642.
    Direct Link:
  • 4
    Bray F, Richiardi L, Ekbom A, et al. Do testicular seminoma and nonseminoma share the same etiology? Evidence from an age-period-cohort analysis of incidence trends in 8 European countries. Cancer Epidemiol Biomarkers Prev. 2006; 15: 652-658.
  • 5
    Bray F, Ferlay J, Devesa SS, McGlynn KA, Moller H. Interpreting the international trends in testicular seminoma and nonseminoma incidence. Nat Clin Pract Urol. 2006; 3: 532-543.
  • 6
    Garner MJ, Turner MC, Ghadirian P, Krewski D. Epidemiology of testicular cancer: an overview. Int J Cancer. 2005; 116: 331-339.
    Direct Link:
  • 7
    Hemminki K, Li X. Familial risk in testicular cancer as a clue to a heritable and environmental aetiology. Br J Cancer. 2004; 90: 1765-1770.
  • 8
    Akre O, Ekbom A, Hsieh CC, Trichopoulos D, Adami HO. Testicular nonseminoma and seminoma in relation to perinatal characteristics. J Natl Cancer Inst. 1996; 88: 883-889.
  • 9
    Aschim EL, Haugen TB, Tretli S, Daltveit AK, Grotmol T. Risk factors for testicular cancer—differences between pure non-seminoma and mixed seminoma/non-seminoma? Int J Androl. 2006; 29: 458-467.
    Direct Link:
  • 10
    Rajpert-De Meyts E, Skakkebaek NE. The possible role of sex hormones in the development of testicular cancer. Eur Urol. 1993; 23: 54-59.
  • 11
    Skakkebaek NE, Rajpert-De ME, Jorgensen N, et al. Germ cell cancer and disorders of spermatogenesis: an environmental connection? APMIS. 1998; 106: 3-11.
    Direct Link:
  • 12
    Johnston LD, O'Malley, PM, Bachman JG. Monitoring the Future National Survey Results on Drug Use, 1975-2002. Volume II: College Students and Adults Ages 19-40 (NIH Publication No. 03-5376). Bethesda, Md: National Institute on Drug Abuse; 2003.
  • 13
    MacCoun R, Reuter P. Interpreting Dutch cannabis policy: reasoning by analogy in the legalization debate. Science. 1997; 278: 47-52.
  • 14
    Michaud PA, Berchtold A, Jeannin A, Chossis I, Suris JC. Secular trends in legal and illegal substance use among 16 to 20 year old adolescents in Switzerland. Swiss Med Wkly. 2006; 136: 318-326.
  • 15
    Kolodny RC, Masters WH, Kolodner RM, Toro G. Depression of plasma testosterone levels after chronic intensive marihuana use. N Engl J Med. 1974; 290: 872-874.
  • 16
    Kolodny RC, Lessin P, Toro G, Masters WH, Cohen S. Depression of plasma testosterone with acute marihuana administration. In: BraudeMC, SzaraS, eds. Pharmacology of Marihuana. New York, NY: Raven; 1976: 699-709.
  • 17
    Wang H, Dey SK, Maccarrone M. Jekyll and Hyde: 2 faces of cannabinoid signaling in male and female fertility. Endocr Rev. 2006; 27: 427-448.
  • 18
    Devane WA, Dysarz FA,III, Johnson MR, Melvin LS, Howlett AC. Determination and characterization of a cannabinoid receptor in rat brain. Mol Pharmacol. 1988; 34: 605-613.
  • 19
    Maccarrone M, Cecconi S, Rossi G, Battista N, Pauselli R, Finazzi-Agro A. Anandamide activity and degradation are regulated by early postnatal aging and follicle-stimulating hormone in mouse Sertoli cells. Endocrinology. 2003; 144: 20-28.
  • 20
    Matsuda LA, Lolait SJ, Brownstein MJ, Young AC, Bonner TI. Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature. 1990; 346: 561-564.
  • 21
    Munro S, Thomas KL, bu-Shaar M. Molecular characterization of a peripheral receptor for cannabinoids. Nature. 1993; 365: 61-65.
  • 22
    Wenger T, Ledent C, Csernus V, Gerendai I. The central cannabinoid receptor inactivation suppresses endocrine reproductive functions. Biochem Biophys Res Commun. 2001; 284: 363-368.
  • 23
    Hankey BF, Ries LA, Edwards BK. The Surveillance, Epidemiology, and End Results program: a national resource. Cancer Epidemiol Biomarkers Prev. 1999; 8: 1117-1121.
  • 24
    FritzAG, PercyC, JackA, et al., eds. International Classification of Diseases for Oncology, 3rd ed. Geneva, Switzerland: World Health Organization; 2000.
  • 25
    Hartge P, Brinton LA, Rosenthal JF, Cahill JI, Hoover RN, Waksberg J. Random digit dialing in selecting a population-based control group. Am J Epidemiol. 1984; 120: 825-833.
  • 26
    Waksberg J. Sampling methods for random digit dialing. J Am Stat Assoc. 1978; 73: 40-46.
  • 27
    Waksberg J. Random digit dialing sampling for case-control studies. In: GailMH, BenichouJ, eds. Encyclopedia of Epidemiologic Methods. New York, NY: John Wiley & Sons; 2000: 749-753.
  • 28
    Harlow BL, Davis S. Two 1-step methods for household screening and interviewing using random digit dialing. Am J Epidemiol. 1988; 127: 857-863.
  • 29
    Liddell FD. Simple exact analysis of the standardised mortality ratio. J Epidemiol Commun Health. 1984; 38: 85-88.
  • 30
    Post PN, Casparie MK, ten Kate FJ, Oosterhuis JW. [The epidemiology of tumors of the testes in the Netherlands: accurate rendering by the Registry of Histopathology and Cytopathology (PALGA)]. Ned Tijdschr Geneeskd. 2004; 148: 1150-1154.
  • 31
    Swerdlow AJ, Stiller CA, Wilson LM. Prenatal factors in the aetiology of testicular cancer: an epidemiological study of childhood testicular cancer deaths in Great Britain, 1953-73. J Epidemiol Commun Health. 1982; 36: 96-101.
  • 32
    Sabroe S, Olsen J. Perinatal correlates of specific histological types of testicular cancer in patients below 35 years of age: a case-cohort study based on midwives' records in Denmark. Int J Cancer. 1998; 78: 140-143.
    Direct Link:
  • 33
    Moller H, Skakkebaek NE. Testicular cancer and cryptorchidism in relation to prenatal factors: case-control studies in Denmark. Cancer Causes Control. 1997; 8: 904-912.
  • 34
    Moller H, Skakkebaek NE. Risk of testicular cancer in subfertile men: case-control study. BMJ. 1999; 318: 559-562.
  • 35
    Rosenkrantz H, Fleischman RW. Effects of cannabis on lungs. In: NahasGG, PatonWDM, eds. Marihuana: Biological Effects. Elmsford, NY: Pergamon Press, Inc; 1979: 279-299.
  • 36
    Lee SY, Oh SM, Chung KH. Estrogenic effects of marijuana smoke condensate and cannabinoid compounds. Toxicol Appl Pharmacol. 2006; 214: 270-278.
  • 37
    Richiardi L, Pettersson A, Akre O. Genetic and environmental risk factors for testicular cancer. Int J Androl. 2007; 30: 230-241.
    Direct Link:
  • 38
    Henderson BE, Bernstein L, Ross RK, Depue RH, Judd HL. The early in utero oestrogen and testosterone environment of blacks and whites: potential effects on male offspring. Br J Cancer. 1988; 57: 216-218.
  • 39
    Howlett AC. Pharmacology of cannabinoid receptors. Annu Rev Pharmacol Toxicol. 1995; 35: 607-634.
  • 40
    Lutz B. Molecular biology of cannabinoid receptors. Prostaglandins Leukot Essent Fatty Acids. 2002; 66: 123-142.
  • 41
    Mechoulam R, Ben-Shabat S, Hanus L, et al. Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors. Biochem Pharmacol. 1995; 50: 83-90.
  • 42
    Piomelli D. The molecular logic of endocannabinoid signalling. Nat Rev Neurosci. 2003; 4: 873-884.
  • 43
    Sugiura T, Kondo S, Sukagawa A, et al. 2-Arachidonoylglycerol: a possible endogenous cannabinoid receptor ligand in brain. Biochem Biophys Res Commun. 1995; 215: 89-97.
  • 44
    Guzman M. Cannabinoids: potential anticancer agents. Nat Rev Cancer. 2003; 3: 745-755.
  • 45
    Patsos HA, Hicks DJ, Greenhough A, Williams AC, Paraskeva C. Cannabinoids and cancer: potential for colorectal cancer therapy. Biochem Soc Trans. 2005; 33: 712-714.
  • 46
    Johansson E, Agurell S, Hollister LE, Halldin MM. Prolonged apparent half-life of delta 1-tetrahydrocannabinol in plasma of chronic marijuana users. J Pharm Pharmacol. 1988; 40: 374-375.
View Full Article (HTML) Get PDF (133K)